No Interaction Expected
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP)
Enfuvirtide (ENF, T20)
Quality of Evidence:
Coadministration has not been studied but based on metabolism and clearance a clinically significant interaction is unlikely. Emtricitabine and tenofovir-DF are eliminated renally. Enfuvirtide undergoes catabolism to its constituent amino acids. This metabolic pathway is unlikely to be affected by coadministered drugs.
View all available interactions with
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP) by clicking